Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Is Moderna a Bad-News Buy?

TheMotleyFool

0 0

We've gotten used to revenue increases from Moderna (NASDAQ: MRNA), so the most recent earnings report may have felt to investors like a bucket of ice water thrown over their heads. The coronavirus vaccine maker posted a 35% drop in third-quarter product sales. And profit fell a whopping 68%.

The company also recorded a charge for inventory write-downs, linked to coronavirus vaccines that went unused.

Does this news mean that demand is falling and it may be time to walk away from Moderna? Or is the stock actually a bad-news buy? Let's find out.

Source Fool.com

Like: 0

MRNA

Share